RhumbLine Advisers
AVAH icon

RhumbLine Advisers’s Aveanna Healthcare AVAH Stock Holding History

RhumbLine Advisers’s Portfolio AVAH Stock Details AVAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$789K Buy
92,031
+26,488
+40% +$187K ﹤0.01% 2475
2026
Q1 		$422K Sell
65,543
-11,509
-15% -$89K ﹤0.01% 2714
2025
Q4 		$630K Buy
77,052
+6,917
+10% +$62.5K ﹤0.01% 2530
2025
Q3 		$622K Sell
70,135
-28
-0% -$177 ﹤0.01% 2547
2025
Q2 		$367K Sell
70,163
-5,418
-7% -$27.5K ﹤0.01% 2871
2025
Q1 		$410K Buy
75,581
+2,918
+4% +$13.8K ﹤0.01% 2699
2024
Q4 		$332K Buy
72,663
+7,257
+11% +$37.2K ﹤0.01% 2932
2024
Q3 		$340K Sell
65,406
-6,051
-8% -$27.4K ﹤0.01% 2960
2024
Q2 		$197K Buy
71,457
+1,114
+2% +$2.78K ﹤0.01% 3231
2024
Q1 		$175K Sell
70,343
-994
-1% -$2.4K ﹤0.01% 3240
2023
Q4 		$191K Sell
71,337
-675
-0.9% -$1.29K ﹤0.01% 3210
2023
Q3 		$85.7K Buy
72,012
+1,071
+2% +$1.66K ﹤0.01% 3510
2023
Q2 		$120K Sell
70,941
-2,179
-3% -$2.73K ﹤0.01% 3447
2023
Q1 		$76K Buy
73,120
+1,350
+2% +$1.6K ﹤0.01% 2887
2022
Q4 		$56K Buy
71,770
+95
+0.1% +$99 ﹤0.01% 2951
2022
Q3 		$108K Buy
71,675
+3,811
+6% +$7.83K ﹤0.01% 2995
2022
Q2 		$153K Buy
67,864
+34,867
+106% +$101K ﹤0.01% 2987
2022
Q1 		$113K Buy
32,997
+2,462
+8% +$13.4K ﹤0.01% 2866
2021
Q4 		$226K Sell
30,535
-664
-2% -$4.83K ﹤0.01% 2801
2021
Q3 		$250K Buy
31,199
+2,090
+7% +$20.3K ﹤0.01% 2838
2021
Q2 		$360K Buy
+29,109
New +$345K ﹤0.01% 2716

Other funds holding AVAH

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
JHWEPV
J.H. Whitney Equity Partners VII New Canaan, Connecticut $232M AUM 63.86% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RhumbLine Advisers's AVAH Position: Q2 2026 in Review

RhumbLine Advisers increased its Aveanna Healthcare (AVAH) stake by 40% in Q2 2026, buying an estimated $187K and bringing the position to 92,031 shares worth $789K. The position accounts for ﹤0.01% of the portfolio, ranked #2475.

RhumbLine Advisers first reported a position in AVAH in Q2 2021 and has held it in 21 quarters since. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • RhumbLine Advisers held 92,031 shares of Aveanna Healthcare worth $789K as of Q2 2026.
  • RhumbLine Advisers bought 26,488 Aveanna Healthcare shares in Q2 2026, an estimated $187K.
  • Aveanna Healthcare made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2475 holding.
  • RhumbLine Advisers first reported a position in Aveanna Healthcare in Q2 2021 and has held it in 21 quarters since.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.